Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection

S Archuleta; B Murphy; M J Keller

doi:10.1111/j.1399-3062.2004.00059.x

Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection

Transpl Infect Dis. 2004 Sep;6(3):117-9. doi: 10.1111/j.1399-3062.2004.00059.x.

Authors

S Archuleta¹, B Murphy, M J Keller

Affiliation

¹ Division of Infectious Disease, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA. soa2002@med.cornell.edu

PMID: 15569227
DOI: 10.1111/j.1399-3062.2004.00059.x

Abstract

Infections with vancomycin-resistant Enterococci cause significant morbidity and mortality in hospitalized patients, including transplant recipients. We report the successful use of oral linezolid to treat a case of vancomycin-resistant Enterococcus faecium endocarditis in a renal transplant recipient with human immunodeficiency virus infection.

Publication types

Case Reports

MeSH terms

Acetamides / therapeutic use*
Anti-Infective Agents / therapeutic use*
Endocarditis, Bacterial / complications
Endocarditis, Bacterial / drug therapy*
Enterococcus faecium / drug effects*
Gram-Positive Bacterial Infections / complications
Gram-Positive Bacterial Infections / drug therapy*
HIV Infections / complications
Humans
Kidney Transplantation* / immunology
Linezolid
Male
Middle Aged
Opportunistic Infections / drug therapy
Oxazolidinones / therapeutic use*
Vancomycin Resistance*
Viral Load

Substances

Acetamides
Anti-Infective Agents
Oxazolidinones
Linezolid